| Fc-mediated anomalous biodistribution of therapeutic antibodies in immunodeficient mouse models SK Sharma, A Chow, S Monette, D Vivier, J Pourat, KJ Edwards, ... Cancer research 78 (7), 1820-1832, 2018 | 83 | 2018 |
| Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect JACM Goos, A Cho, LM Carter, TR Dilling, M Davydova, K Mandleywala, ... Theranostics 10 (2), 567, 2020 | 79 | 2020 |
| Exploring structural parameters for pretargeting radioligand optimization JP Meyer, P Kozlowski, J Jackson, KM Cunanan, P Adumeau, TR Dilling, ... Journal of medicinal chemistry 60 (19), 8201-8217, 2017 | 65 | 2017 |
| Bioorthogonal masking of circulating antibody–TCO groups using tetrazine-functionalized dextran polymers JP Meyer, KM Tully, J Jackson, TR Dilling, T Reiner, JS Lewis Bioconjugate chemistry 29 (2), 538-545, 2018 | 46 | 2018 |
| HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy EM Stevenson, AR Ward, R Truong, AS Thomas, SH Huang, TR Dilling, ... JCI insight 6 (3), 2021 | 39 | 2021 |
| Noninvasive 89Zr-transferrin PET shows improved tumor targeting compared with 18F-FDG PET in MYC-overexpressing human triple-negative breast cancer KE Henry, TR Dilling, D Abdel-Atti, KJ Edwards, MJ Evans, JS Lewis Journal of Nuclear Medicine 59 (1), 51-57, 2018 | 33 | 2018 |
| Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue JACM Goos, M Davydova, TR Dilling, A Cho, MA Cornejo, A Gupta, ... Nuclear medicine and biology 84, 63-72, 2020 | 21 | 2020 |
| Polyazamacrocycle Ligands Facilitate 89Zr Radiochemistry and Yield 89Zr Complexes with Remarkable Stability DN Pandya, KE Henry, CS Day, SA Graves, VL Nagle, TR Dilling, A Sinha, ... Inorganic chemistry 59 (23), 17473-17487, 2020 | 19 | 2020 |
| A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer KE Henry, MM Dacek, TR Dilling, JD Caen, IL Fox, MJ Evans, JS Lewis Clinical Cancer Research, clincanres. 1485.2018, 2018 | 19 | 2018 |
| A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies CD McCann, CH van Dorp, A Danesh, AR Ward, TR Dilling, TM Mota, ... Journal of Experimental Medicine 218 (7), e20201908, 2021 | 14 | 2021 |
| ERK inhibition improves anti–PD-L1 immune checkpoint blockade in preclinical pancreatic ductal adenocarcinoma KE Henry, KN Mack, VL Nagle, M Cornejo, AO Michel, IL Fox, ... Molecular cancer therapeutics 20 (10), 2026-2034, 2021 | 12 | 2021 |
| Star polymers for PET/MRI: a passive pretargeting approach J Goos, S Puttick, T Dilling, A Gupta, W Price, J Quinn, M Whittaker, ... Journal of Nuclear Medicine 59 (supplement 1), 195-195, 2018 | 3 | 2018 |
| Dynamics of HIV-specific T cells on long-term ART differ by antigen recognised and by sex EM Stevenson, AR Ward, TR Dilling, JK Bui, J Mellors, R Gandhi, ... | 2 | 2019 |
| Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617 JC Dos Santos, M Schäfer, U Bauder-Wüst, B Beijer, M Eder, K Leotta, ... Frontiers in Chemistry 10, 898692, 2022 | 1 | 2022 |
| Interrogating KRAS, ERK, and MYC Signaling in Pancreatic Cancer with Endogenous PET Imaging K Henry, M Dacek, T Dilling, J Caen, M Evans, J Lewis Journal of Nuclear Medicine 59 (supplement 1), 72-72, 2018 | 1 | 2018 |
| HIV-specific T-cell responses reflect substantive in vivo interactions with infected cells despite long-term therapy EM Stevenson, AR Ward, R Truong, AS Thomas, SH Huang, TR Dilling, ... bioRxiv, 2020.08. 28.272625, 2020 | | 2020 |
| 4308 DEEP-PRIMED IL-15 SUPERAGONIST IMPROVES ANTIVIRAL EFFICACY OF HIV-SPECIFIC CD8+ T-CELLS IN HUMANIZED MOUSE MODEL CD McCann, E Zale, A Ward, T Dilling, A Danesh, E Stevenson, T Mota, ... Journal of Clinical and Translational Science 4 (s1), 4-5, 2020 | | 2020 |
| DEEP-PRIMED IL-15 SUPERAGONIST IMPROVES ANTIVIRAL EFFICACY OF HIV-SPECIFIC CD8+ T-CELLS IN A HUMANIZED MOUSE MODEL C Mccann, E Zale, A Ward, T Dilling, A Danesh, E Stevenson, T Mota, ... HUMAN GENE THERAPY 30 (12), A9-A10, 2019 | | 2019 |
| Altering the tumor microenvironment to improve immunotherapy: Molecular imaging of PD-L1 in pancreatic cancer K Henry, M Davydova, T Dilling, I Fox, J Lewis ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
| Teaching old ligands new tricks: macrocyclic chelators for zirconium-89 radiochemistry K Henry, D Pandya, B Nikunj, V Nagle, T Dilling, T Wadas, J Lewis Nuclear Medicine and Biology 72, S15, 2019 | | 2019 |
Jason S. LewisMSKCCVerified email at mskcc.org
